
Q&A With Consultant Terri Welter: Is Value-Based Care Stalling?
ECG Management Consultants’ Terri Welter says Medicaid presents a big opportunity to shift to value-based care, while the commercial insurers will probably be the last to do it
ECG Management Consultants’ Terri Welter says Medicaid presents a big opportunity to shift to value-based care, while the commercial insurers will probably be the last to do it
Nationwide, an estimated 52 million nonelderly adults live with mental illness, and Medicaid covers nearly one in three (29%) of them, or about 15 million adults. More than 1 in 3 Medicaid enrollees has a mental illness. Mental health treatment rates for Medicaid adults are higher than or similar to those with insurance.
Blood centers are neutral partners, as they do not compete with hospitals for patients. Instead, they complement hospitals by providing a focused array of high-quality, specialized, patient-centric services, allowing hospitals to maintain primary relationships with patients and their families. The post Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access appeared first on…
Collecting patient payments is an ongoing struggle. Bills are confusing, reminders go missed and patients can’t always afford to pay. Rising self-pay costs, new medical debt mitigation regulations, Medicaid changes and staff shortages all put added pressure on billing teams. The result is often poor patient financial experiences, wasted staff time and bad debt. As…
Medicaid is under threat — again. Republicans, who narrowly control Congress, are pushing proposals that could sharply cut funding to the government health insurance program for poor and disabled Americans, as a way to finance President Donald Trump’s agenda for tax cuts and border security. Democrats, hoping to block the GOP’s plans and preserve Medicaid…
Texas is moving to allow for more freedom of choice with respect to receipt of vaccines. The Economist reports: Texas legislators meeting in Austin, the state capital, are debating new laws to relax vaccine rules, urged on by Texans for Vaccine Choice (TFVC). On February 18th activists in “Come and Make Me” shirts took to…
This year’s ViVE conference was full of announcements — from acquisitions to rebrands to product launches. This list compiles short summaries for seven of the conference’s most notable announcements. The post 7 ViVE Announcements You Don’t Want to Miss appeared first on MedCity News.
Millie’s Series A round was co-led by TMV and Foreground Capital. The financing will help the company expand its offerings and footprint. The post Millie Raises $12M to Advance Maternal Healthcare appeared first on MedCity News.
In an interview, VideaHealth CEO Florian Hillen says a new funding round will focus on enhancing customer service, expanding partnerships, and developing new AI-driven administrative tools
FibroGen secured regulatory approvals for roxadustat in China and Europe, but the FDA rejected the drug and asked for another clinical trial. By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication. The post AstraZeneca Secures China Rights to Anemia…